Vaxfab Enterprises Intrinsic Value
Vaxfab Enterprises (VEL) median intrinsic value is ₹99.10 from 2 valuation models (range ₹19–₹99), vs current price ₹49.55 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Also explore Vaxfab Enterprises share price performance to track price trends across different timeframes.
VEL Valuation Methods Summary — DCF, Graham Number & P/E
Vaxfab Enterprises intrinsic value across 2 models vs current price ₹49.55 — upside/downside and value range per method. Browse Vaxfab Enterprises annual reports for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹18.89 | ₹17.00 - ₹20.78 | -61.9% | Book Value/Share: ₹18.89, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹99.10 | ₹89.19 - ₹109.01 | +100.0% | Revenue/Share: ₹231.11, P/S: 0.8x |
VEL Intrinsic Value vs Market Price — All Valuation Models
Vaxfab Enterprises fair value range ₹19–₹99 vs current market price ₹49.55 across 2 valuation models. For current market price and key ratios, visit VEL share price screener.
VEL Intrinsic Value Analysis — Undervalued or Overvalued?
Vaxfab Enterprises median intrinsic value ₹99.10, current price ₹49.55 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of VEL?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Vaxfab Enterprises (VEL) is ₹99.10 (median value). With the current market price of ₹49.55, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹18.89 to ₹99.10, indicating ₹18.89 - ₹99.10.
Is VEL undervalued or overvalued?
Based on our multi-method analysis, Vaxfab Enterprises (VEL) appears to be trading below calculated value by approximately 100.0%.
VEL Financial Health — Key Ratios vs Industry Benchmarks
Vaxfab Enterprises financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | -47.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 7.70x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
VEL Cash Flow Quality — Operating & Free Cash Flow
Vaxfab Enterprises operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2023 | ₹2 Cr | ₹-4 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |